KHPG(SZ:002773) Zheng Quan Zhi Xing·2025-08-27 16:41Core Viewpoint - Chengdu Kanghong Pharmaceutical Group Co., Ltd. has announced that the conditions for the third exercise period of the 2021 stock option incentive plan have been met, allowing two incentive objects to exercise a total of 35,400 stock options at a price of 13.84 yuan per share [1][11]. Summary by Sections Stock Option Incentive Plan Overview - The 2021 stock option incentive plan includes a total of 1,207,000 stock options granted to 410 incentive objects, with adjustments made to the plan as necessary [2][3]. - The plan's first grant date was set for July 19, 2021, and the third exercise period is from July 11, 2025, to July 10, 2026 [1][11]. Conditions for Exercise - The waiting period for the third exercise period has expired, allowing eligible incentive objects to exercise their options [11][13]. - The conditions for exercising the options include no negative audit opinions on financial reports and compliance with performance assessments [11][15]. Exercise Details - A total of 35,400 stock options can be exercised by the two incentive objects, representing 0.0038% of the company's total share capital of 921,320,954 shares [11][15]. - The exercise price for the options is set at 13.84 yuan per share, adjusted from a previous price of 14.44 yuan [11][17]. Impact on Company - The exercise of stock options is not expected to significantly impact the company's shareholding structure or listing conditions [19]. - The funds raised from the exercise will be used to supplement the company's working capital [20]. Compliance and Approval - The board and supervisory committee have reviewed and approved the exercise conditions, confirming that they meet legal and regulatory requirements [21][22]. - A legal opinion has been issued confirming that the exercise and cancellation of stock options comply with relevant regulations [21][22].